These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 1871923)
1. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders]. Ermolenko VM; Lifshits NL; Zisel'man SB; Tatsievskiĭ VA Urol Nefrol (Mosk); 1991; (3):41-8. PubMed ID: 1871923 [TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension in patients on chronic hemodialysis]. Zogović J; Mladenović Lj Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of captopril (Tensiomin) in patients with hypertension. Török E; Bíró V; Wagner M; Kósa E; Podmaniczky M; Cseh K Acta Physiol Hung; 1988; 72 Suppl():51-65. PubMed ID: 2908092 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Lebel M; Rodrigue ME; Agharazii M; Larivière R Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776 [TBL] [Abstract][Full Text] [Related]
5. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470 [TBL] [Abstract][Full Text] [Related]
6. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin. Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302 [TBL] [Abstract][Full Text] [Related]
7. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
8. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients. Hirakata H; Onoyama K; Hori K; Fujishima M Clin Nephrol; 1986 Jul; 26(1):27-32. PubMed ID: 3524928 [TBL] [Abstract][Full Text] [Related]
9. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems. Ohman KP; Karlberg BE; Nilsson OR; Wettre S Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190 [TBL] [Abstract][Full Text] [Related]
10. [Captopril in the treatment of arterial hypertension in chronic nephritis]. Kutyrina IM; Rogov VA; Lifshits NL; Klepikov PV Ter Arkh; 1986; 58(8):92-6. PubMed ID: 3532416 [TBL] [Abstract][Full Text] [Related]
11. [Long-term treatment with captopril in arterial hypertension complicated by renal failure]. Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy of captopril in periarteritis nodosa with arterial hypertension and renal failure (author's transl)]. Guillevin L; Leenhardt A; Herson S; Bletry O; Godeau P Nouv Presse Med; 1981 Apr; 10(19):1592-3. PubMed ID: 6116493 [TBL] [Abstract][Full Text] [Related]
13. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]
14. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
15. [Captopril in the treatment of essential hypertension (author's transl)]. Lederle RM; Klaus D; Braun B Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors in hypertension: a review. Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182 [TBL] [Abstract][Full Text] [Related]
17. [Long term treatment of resistant hypertension with captopril (author's transl)]. Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846 [TBL] [Abstract][Full Text] [Related]
18. Acute changes in the renin-angiotensin-aldosterone system, catecholamines and prostaglandins during captopril in man. Lijnen P; Verschueren LJ; Fagard R; Staessen J; Amery A Methods Find Exp Clin Pharmacol; 1980 Dec; 2(6):293-301. PubMed ID: 6152995 [TBL] [Abstract][Full Text] [Related]
19. Neurohormonal responses to antihypertensive treatment with captopril or hydrochlorothiazide. Rabinad E; Gaya J; Rivera F; Ingelmo M; Balcells A Postgrad Med J; 1986; 62 Suppl 1():143-5. PubMed ID: 3534850 [TBL] [Abstract][Full Text] [Related]
20. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure]. Lifshits NL; Kutyrina IM Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]